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Pathogenesis in the Space Environment
The boundary of space, according to the ofﬁcial deﬁnition
of the International Aeronautics Federation, sits at an altitude of
100 km above sea level,6 although the transition to space
actually involves a series of boundaries progressively more
hostile to human existence.7 The space stations in low Earth
orbit travel at an altitude of 220 to 280 miles (350 to 450 km)
and a speed of 17,500 mph (28,000 km/h). This velocity
generates a centrifugal force capable of compensating Earth’s
gravity, which at this altitude is still 88% of sea level’s gravity.
Both forces counterbalance each other, leading to the state of
weightlessness, or microgravity.
In addition to the “conventional” medical conditions that
threaten every human being, the unique environment of space-
ﬂight, and in particular the loss of gravity, may predispose a
person to the onset of a number of speciﬁc illnesses unique to
space travel and especially prolonged weightlessness. Both types
of conditions are summarized in Table 1.8 The majority of this
list overlaps with the risks identiﬁed by the National Aeronautics
and Space Administration (NASA) Human Research Roadmap.9
The phases of launch and landing are extremely critical due
to the stress put on the vehicles (and, subsequently, the crew
within) by tremendous changes in velocity (accelerations and
decelerations), and indeed, all human losses during spaceﬂightJournal of Cardiothoracic and Vascular Anesthesia, Vol 30, No 3 (June), 2have occurred during those transition phases (Challenger,
Columbia, Soyuz 1, and T11).10
The latest NASA Mars mission design concept corresponds to a
6-person crew conducting a 900-day mission.11 Recently, a NASA
report outlined “deep space” cislunar missions for the 2020s
followed by a Mars mission in the 2030s for “at least 4 crew”
for “up to 1,100 days.”12 In deep space, the vast distances involved
imply that real-time communications will not remain possible, with
delays between Earth and Mars, for example, reaching 4 to
20 minutes in each direction. An unprecedented level of crew
autonomy will be necessary, including for medical care. With
electronic transmissions limited by the speed of light, telemedicine,
telementoring, and telesurgery all become impractical options. The
exact crew composition has not been decided, but could be limited
to a crew medical ofﬁcer who is not necessarily a physician.13 An
astronaut survey argued against this and recommended having a
medical doctor with broad medical skills on board.13
Inside any spacecraft, astronauts absolutely rely on the
Environmental Control and Life Support Systems (ECLSS) to
maintain an atmosphere that can sustain human life that is steady,
normoxic, and normobaric, with neutral temperatures. Inside the
cabin, the carbon dioxide concentration is on average 10 times
higher than on the ground (0.3%-0.5%). An extremely hostile
environment lies outside the vessel, marked by a nil barometric
pressure, high levels of radiation, and extreme temperatures
(-1501 to þ1201C).14 Living in a closed environment involves
an immediate vital risk in the possible loss of cabin pressure
(eg, if a meteorite or satellite debris were to hit the station), ﬁre,
release of toxic substance, or malfunction of the ECLSS.5,15016: pp 781–790 781
Table 1. Earth-like and Space-speciﬁc Medical Conditions in Space
Earth-Like Conditions Space-Speciﬁc Conditions
Trauma Cardiovascular deconditioning
Infections Radiation exposure
Cardiovascular diseases:
arrhythmias, myocardial
ischemic events, stroke
Vision impairment and
intracranial pressure
syndrome
Renal stone Hypobaric decompression
sickness
Psychiatric disorders Exposure to a toxic
atmosphere
Cataract Hypothermia/heat stroke
Cancer Exposure to planetary dust
(Adapted from Komorowski M, Neuhaus C, Hinkelbein PDJ: Emer-
gency medicine in space. Notfall Rettungsmed 18:268-273, 2015.8)
Fig 1. Timescale of the deadaptation of human systems to
weightlessness. (Reproduced with permission from Nicogossian
AE, Parker J, et al: Space physiology and medicine. CreateSpace
Independent Publishing Platform, 2012.)34
KOMOROWSKI ET AL782When astronauts perform spacewalks (extravehicular activ-
ities [EVAs]), they transition into a hypobaric (300 to 400 hPa),
pure oxygen environment inside an EVA suit.16 Reproducing
such a decompression proﬁle in a hypobaric chamber results in
a 50% to 80% occurrence of venous bubbles or decompression
sickness (DCS) symptoms.16 Very few actual cases in space
have been reported, possibly because microgravity and the
EVA suit provide protection against DCS, but also because
astronauts likely underreport the issue.17,18 There also is a
theoretical risk of barotrauma and subsequent pneumothorax
with such activities.19 Suits pressurized at 565 hPa (tissue ratio
of 1.4) and running 34% oxygen (normoxic mixture) are
envisioned by NASA for Mars exploration EVAs and would
eliminate the need for denitrogenation and drastically limit the
risk of DCS altogether.12,17
Living in an enclosed and isolated environment has
profound physiologic and psychologic effects, such as immu-
nodepression, sleep and mood disturbances, and decrease in
cognitive performance.20
The astronauts in low Earth orbit are somewhat protected
from radiation by the Van Allen magnetosphere belts.21
Beyond those, no effective shielding technology currently
exists, and the exposure to solar particle events could have
dramatic consequences such as acute radiation sickness.22
Radiation in space also seems to increase the risk of cancer,
infertility, and cataract.21 The NASA Longitudinal Study of
Astronaut Health identiﬁed an increase in mortality from
cancer, which fortunately has been below the signiﬁcance
level.23
Concerns related to the potential health effects of inhalation
of planetary dust have been raised since irritation symptoms of
the skin and airway were described by Apollo astronauts.24
The conditions of highest concern include major trauma and
hemorrhagic shock3,5; orthostatic intolerance upon re-exposure
to gravity and reduction of aerobic capacity25; ionizing
radiation21,22; the psychologic effect of isolation and chronic
stress20; and challenges regarding the delivery of surgery,
anesthesia, and subsequent critical care.26-28 Realistically, the
human management of severe trauma and surgical conditions
implies the capability to provide anesthesia.3,5,29
Experts have estimated the risk of a serious medical event
during a mission to be around 0.06 per person-year of ﬂight,which corresponds to 1 event per 2.8 years for a crew of 6 (ie, 1
emergency during a 900-day mission to Mars).4,30-32
The individual risk of death from illness or trauma during an
exploration mission to Mars has been estimated to be 0.24%
per year.4 In comparison, the observed mortality risk on Earth
in high income countries and in the age range of 30 to 59 years,
is 0.39% per year.33 To put these numbers in perspective, the
safety objective for the individual risk of death from spacecraft
failure is 3% per year, or 12 times higher than death of medical
origin.4 However, regardless of population statistics, planning
for medical care in expeditionary spaceﬂight involves hard
decisions regarding whether capabilities to attempt treatment of
catastrophic illness will be provided or whether realities of the
mission will mandate that such catastrophes are simply
palliated, and if so, whether the remains will be preserved or
“buried in space.”28Human Adaptation to Space
More than 50 years of space medicine research has provided
a reasonably good picture of how human physiology is affected
by spaceﬂight.10 The human body has evolved millions of
years under gravity and is thus adapted for this environment.
Weightlessness fundamentally affects most, if not all, physio-
logic systems (Fig 1).34 Of greatest concern, these effects of
microgravity on several systems (eg, bone demineralization) do
not reach a plateau, with deadaptation seemingly continuing
relentlessly as long as weightlessness persists.Cardiovascular System
From the point of view of the anesthesiologist and when
considering urgent medical care during or immediately after
spaceﬂight, the cardiovascular system is undoubtedly one of
the most critical to consider. Weightlessness induces profound
cardiovascular changes, which are summarized in Table 2.35-50
In the human body, the equilibrium among the different
functional ﬂuid compartments of the vascular system, most
notably the venous capacitance vessels, is largely under the
control of gravity.35,51 When entering weightlessness, ﬂuid is
redistributed toward the upper body, a phenomenon referred to
Table 2. Main Cardiovascular Changes Occurring in Weightlessness
Parameter Change in Weightlessness
Heart rate Initially ▼, then ►10
Blood pressure Initially ▼, then ▼ or ►10,35
Central venous pressure Paradoxically ► or ▼36-39
Blood volume ▼ 9% to 17%36,40-43
Intracellular ﬂuid ▲40,43
Cardiac systolic function ►25
Cardiac diastolic function ▼25
Systemic vascular
resistances
▼ 14%  9%44; ▼39%35
Cardiac output Initially ▲, then ▼ 17% to 20%10
or ▲ 41%35
Baroreﬂex ▼ 50%36,45,46
Aerobic capacity: VO2
max
▼ 22%10
Red blood cell mass ▼ 10%41,47,48
Endothelial function Deﬁcit in vasoconstriction49,50
NOTE.▼ Reduction, ▲ Increase, ► No change.
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facial edema and the so-called “chicken legs.”10
Leach et al have shown that in response to early weightless-
ness, there is a profound diuresis, presumably from the
physiologic response to perceived hypervolemia, as the large
intravascular ﬂuid volumes previously localized to the venous
capacitance vessels are released to the central circulation.40,43
Subsequently, the plasma volume is reduced from 3.5 to 3.1 L
after 1 week in space, whereas the intracellular volume increases
from 23.9 to 26.3 L.40,43 Similar results have been obtained
using a dilution technique of radioisotopes.47 Blood volume has
been shown to decrease by 9% to 17% as early as day 1, which
represents up to 1 L for a 70-kg man.36,40-42 Multiple mecha-
nisms are involved in the reduction of the plasma volume,
including a decrease in oral intake (even in the absence of space
motion sickness) and ﬂuid shifts toward interstitial and intra-
cellular spaces.36 Diuresis does not seem to be increased.36Fig 2. Cardiac ejection fraction (%) at rest and at exercise before
Abbreviation: HDBR, head-down bed rest. (Adapted with permission fro
spaceﬂight does not support the NASA Bioastronautics Critical Path RoaThe red blood cell mass drops signiﬁcantly by about 10%
after 1 week in weightlessness.41,47,48 A possible explanation
for this “space anemia” lies in the inhibition of erythropoiesis
in space, secondary to the increase in kidney tissue oxygen
partial pressure. Indeed, the ﬂuid shift toward the upper body is
associated with an increase in oxygen transport in this area.52
Another hypothesis could be hemolysis, as suggested by the
increase in ferritine (þ35 to 46%) that has been measured.42,52
Heart rate and blood pressure are affected little by weight-
lessness, but some authors have suggested that they may
decrease marginally.10,35,53
Initially, because of the headward ﬂuid shift, stroke volume
and cardiac output are increased (þ20 to 50%).10 After a few
days of adaptation, mostly as a result of hypovolemia but also
cardiac atrophy, the ejection fraction increases and the stroke
volume decreases (only possible if the decrease in end-diastolic
volume exceeds the reduction in stroke volume).25,54,55 At this
point, the drop in cardiac output can reach 17% to 20%.10,25 A
reduction in left ventricle mass of 8% to 14% has been
reported.41,56 Even though diastolic dysfunction clearly has
been identiﬁed in astronauts and prolonged bed rest studies, the
left ventricular systolic function seems to be little affected, if at
all (Fig 2).25
The risk of arrhythmias is increased in space, particularly
during EVAs, due to catecholamine discharge.24,25,57 In 1987,
a cosmonaut was evacuated from MIR after a 14-beat run of
ventricular tachycardia.10
It has been estimated that the baroreﬂex response was
blunted by 50% after only 1 day in space.45 Some suggest
that short-term spaceﬂight does not alter the baroreﬂex,58 but
all agree that it is inhibited after long-duration spaceﬂight and
that those changes can last for up to 2 weeks after returning to
Earth.36,46
Systemic vascular resistances are decreased by 14%  9%
after 1 week of weightlessness as a result of systemic arterial
vasodilatation.35,44 Paradoxically, given the headward ﬂuid
shift, the central venous pressure is not increased and may
even decrease.36 Of note, central venous pressure has beenand after spaceﬂight (left panel) and bed rest study (right panel).
m Convertino VA, Cooke WH: Evaluation of cardiovascular risks of
dmap. Aviat Space Environ Med 76:869-876, 2005.25)
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catheter inserted through an arm vein!37,38 Among the hypoth-
eses, some have suggested the reduction in intrathoracic
pressure or the loss of gravitational force on the cardiac
muscle.39 The systemic vasodilatation and lower blood pres-
sure might be beneﬁcial during long-duration missions.35,44
Weightlessness induces endothelial changes.49,50,53,59
The loss of gravitational constraint and the important
reduction of motor activity alter regional blood ﬂow and
vascular transmural pressure,60 which induce an adaptation
of vasomotor tone, and in the long term vascular remodeling.
The structural changes involve all layers of blood vessels but
predominate in the endothelium and the smooth muscular
cells.59 Release of proinﬂammatory molecules could con-
tribute to the endothelial changes.53 Animal studies in the rat
have identiﬁed similar endothelial changes after experimen-
tal endotoxinemia and antiorthostatic hypokinesia (hindlimb
unloading by tail suspension, a model of weightlessness),
suggesting that the endothelial dysfunction after spaceﬂight
could be linked to an increase in endotoxin translocation
from the gut.61 Finally, weightlessness could alter cellular
survival mechanisms and induce signals causing apoptosis.62
The changes lead to endothelial dysfunction with a deﬁcit of
vasoconstriction that contributes to the orthostatic intoler-
ance after landing.49,50
Changes in adrenergic-receptor sensitivity have been iden-
tiﬁed and contribute to a syndrome sometimes referred to as
“syndrome of inadequate sympathetic response after exposure
to microgravity.”63 Most agree that the sensitivity of beta-
adrenergic receptors is increased, and the sensitivity of alpha-
adrenergic receptors is decreased.36,64 Agnew et al suggested
that these changes have therapeutic consequences and recom-
mended limiting the use of adrenergic antagonists and poten-
tially increasing the dosing of alpha-agonist agents.36,64Other Systems
In weightlessness, the gravitational stimuli disappear, which
leads to conﬂicts between the sensory organs and alters, in
particular, spatial orientation, balance, gaze control, and
autonomous vestibular function.65 These disturbances induce
a form of space-speciﬁc motion sickness in about two-thirds of
astronauts.66 It can last up to a few days and frequently
reappears after landing.66 The international space medicine
community has expressed growing concerns regarding changes
in visual acuity after spaceﬂight. This syndrome appears to be
related to an increase in intracranial pressure and is now
referred to as “vision impairment and intracranial pressure”
syndrome.67,68 The constant exposure to artiﬁcial light affects
sleep and circadian rhythms aboard spacecrafts, and lighting is
now provided on the International Space Station (ISS) by
speciﬁc solid-state lights developed to provide a more
appropriate spectrum.69 Maintaining crew mental health, cohe-
sion, and performance during a several-year mission will be
essential and highly dependent on the success of the crew
selection process.20
The loss of physical stimulus on the skeleton leads to a 1%
loss of bone mineral density per month on average and can
exceed 2% per month in the pelvic area.10,64 The heavy-resistive exercise regimen followed by current astronauts on the
ISS is able to counterbalance bone loss by increasing bone
formation, resulting in an overall maintained bone mineral
density compared with earlier space programs.70 The quality of
the bone nevertheless remains doubtful, and the risk of fracture
(in particular at the hip level) might be increased despite a
maintained bone mineral density.4,70 Increase in urinary
calcium due to bone resorption and a reduction in diuresis
signiﬁcantly amplify the risk of kidney stones.70,71 A few cases
have occurred in the past.3,72 Underused groups of muscles
(back, abdominal wall, lower limbs) show a decrease in peak
strength and endurance of up to 25%.73 The diaphragm most
likely is not affected.
Compared with preﬂight measurements, the respiratory
rate is increased in space (þ9%) and the tidal volume is
reduced (-15%), leading to an overall unchanged alveolar
ventilation.74 The functional residual capacity is increased,
which could in theory reduce the risk of atelectasis during
mechanical ventilation.74,75 In the absence of gravity, the
ventilation:perfusion ratio becomes homogenous, which
could improve hematosis. The total alveolocapillary surface
may be increased and thus improve the lung diffusing
capacity.74,76 Initial studies in parabolic ﬂight demonstrated
that spontaneous changes in thoracoabdominal compliance
fundamentally were beneﬁcial to pulmonary function.77 The
impairment of pulmonary mechanics due to intraabdominal
pathology and subsequent intraabdominal hypertension is a
critical factor in the provision of life support and ventilatory
management in particular.78,79 Fortunately, it has been
determined that the relative impairment in pulmonary func-
tion typically created by intraabdominal hypertension and
intraabdominal gas insufﬂation (in the case of laparoscopy) is
ameliorated by weightlessness.77
Immune system dysregulation in space has been con-
ﬁrmed.80 The incidence of infectious disorders during space-
ﬂight is increased, affecting, for example, 50% to 60% of
Apollo crew members.24,80 The likelihood of infections
may be further increased by changes in bacterial virulence in
space.64,81
Gastrointestinal motility is signiﬁcantly slower in space, at
least during the ﬁrst 72 hours of the ﬂight.32 A rise in gastric
content acidity has been reported.82 Astronauts generally
exhibit a loss of body weight, proportional to the duration of
the ﬂight, which reaches, for example, 5% on average after 6
months on the ISS83 and is attributed to an imbalance between
caloric intake and expenditures.84
The readaptation of human physiology in space is only one
of the factors that complicate medical care during space
missions. The second section of this review recapitulates those
factors, with a particular focus on anesthesia.CHALLENGES FOR THE DELIVERY OF ANESTHESIA
The delivery of advance medical care such as anesthetic
procedures is complicated in the space environment by many
factors that schematically fall into the following 2 catego-
ries: lack of technologies to actually perform the procedure
and lack of knowledge about which protocol to choose
(Table 3).
Table 3. Summary of Missing Technologies and Knowledge for the
Provision of Anesthesia During Space Exploration Missions
Missing Technologies Missing Knowledge
Intravenous (IV) ﬂuid and
vascular access
Physiology
 IV ﬂuid generation
 IV ﬂuid handling
 Lack of rapid vascular
access capability
 Cardiovascular physiology in
microgravity and partial gravity
 Prevention and mitigation of
orthostatic intolerance and loss of
aerobic capacity
Medical equipment Pharmacology
 Complete set of medical
equipment fulﬁlling
spaceﬂight standards and
restrictions
 Prevention of oxygen
buildup in the cabin
 Design of medical kits
 Pharmacokinetics and
pharmacodynamics of drugs
 Safety and dosing of vasopressors
and inotropes
Drugs conservation Anesthetic technique
 Best general anesthesia protocol
 Role of regional and perimedullary
techniques
Lack of onboard expertise Medical training
 Expert medical decision
support systems
 No telemedical link for
distant missions
 Proﬁle of crew medical doctor
 Preﬂight and inﬂight training
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Fluid Generation and Handling
Shipping and storing intravenous (IV) ﬂuids in a spacecraft
is expensive and uses precious stowage volume. IV ﬂuids are
unlikely to be used and have a limited shelf-life. The capacity
to generate onsite and on-demand IV ﬂuid from drinking water
is highly desirable. A demonstration prototype was tested
successfully on the ISS (project IVGEN).85 Fluid handling
and drug preparation are complicated in space because ﬂuids
and gas do not separate spontaneously (Fig 3).29 NASA experts
are conﬁdent that this is not a major issue and that efﬁcient
techniques of air bubble removal exist.86Fig 3. Behavior of intravenous ﬂuids in space. (Reproduced with
permission from Norﬂeet W: Anesthetic concerns of spaceﬂight.
Anesthesiology 98:1219, 2000.)29Medical Equipment
Advanced medical care typically requires a set of speciﬁc
equipment such as a monitor, ventilator, suction equipment,
and oxygen concentrator. Spaceﬂight imposes a number of
restrictions in terms of weight, size, and power consumption in
addition to compliance with speciﬁc spaceﬂight standards. The
NASA Human Research Roadmap-Exploration Medical Capa-
bility group has demonstrated a concept of an integrated
platform, inspired by military equipment and requirements.87
Any medical procedure involving the administration of
supplemental oxygen to a crewmember implies the risk of
oxygen buildup in the closed cabin environment, with major
risks of explosion and ﬁre.29 This will have to be addressed by
either limiting the dumping of oxygen in the cabin (closed
ventilation circuit) or effective oxygen removal by the ECLSS.
The use of volatile anesthetics will be prohibited, therefore anygeneral anesthetic will have to be administered exclusively via
the IV route.26
Vascular access might be difﬁcult to obtain in a medical
contingency. An intraosseous access kit has been integrated
into the ISS medical gear. The use of ultrasound, potentially
operating autonomously or robotically, to obtain central
vascular access is another option, with such development
ongoing.88 In general, ultrasound has been shown to be a very
useful and practical tool for use in spaceﬂight.19,89,90
Related Risks and Gaps
Many other factors, not directly related to the provision of
anesthesia, will complicate the provision of advanced medical
care. For example, most current blood products are of human
origin and have a limited shelf-life. The availability of blood
substitutes (eg, synthetic hemoglobin) would drastically
improve the survivability after severe trauma.5 Current shock
resuscitation strategies emphasize earlier use of blood products
and colloids, with dramatically less crystalloid ﬂuids admini-
stered.91
Several other limitations of missing knowledge or equip-
ment have been identiﬁed in the following ﬁelds: on-board
medical expertise, adapted medical protocols for resource-poor
settings, telemedicine (especially for distant missions), non-
invasive medical imaging, minimally invasive laboratory test-
ing, bone fracture stabilization and wound healing, medical
equipment sterilization, body sounds auscultation, medical data
management, medical supplies inventory management, and risk
of ineffective or toxic medications after long-term storage.92
Challenges Due to Missing or Incomplete Knowledge
Incomplete Knowledge About Human Physiology in Partial
Gravity
Gravity on the Moon and Mars is about one-sixth and one-
third of Earth’s, respectively. Precise knowledge about human
adaptation to partial gravity levels is required and will affect
mission planning and medical preparation.64 Artiﬁcial gravity
could provide an effective global countermeasure against bone,
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very little is known about human physiology in partial
gravity.14,94 The Apollo moon missions did not include
extensive physiologic experiments.24
The only available data, obtained in parabolic ﬂight, head-
up tilt and lower body unweighting experiments, provided
answers to short-term changes from transitioning from 1G to
partial gravity levels.94-96 It is critical to understand the
physiologic impact of prolonged stays (days to weeks) in
reduced gravity levels. What is the minimum level of gravity
required to maintain ﬁtness and prevent deconditioning? An
important consideration for mission planning is determining
whether daily physical exercise is necessary in reduced
gravity.
One way to address questions such as these with current
technologies would be to install a short-arm centrifuge on the
ISS and test the physiologic responses to various levels of
gravity (project currently on hold). The ground research on the
question is active, a recent study on a short-arm centrifuge
suggesting that 0.75G at the heart level (2G at feet level)
produces similar cardiovascular stimulus to standing.97Challenges Related to Cardiovascular
Changes in Space
A reduced aerobic capacity historically has been measured
during spaceﬂight.10 Thanks to the intense countermeasure
regimen, many are nowadays able to maintain or even improve
their aerobic capacity.41,64 Cardiovascular changes and hypo-
volemia lead to orthostatic intolerance on return to gravity in
about 80% of astronauts after 6 months on the ISS.51 This
condition has, in some cases, required administration of IV
drugs and ﬂuid.64 Immediately after landing, the aerobic
capacity is impaired because of hypovolemia, anemia, and
orthostatic intolerance.25,43,63 This, along with the space
motion sickness, may compromise astronauts’ ability to per-
form critical tasks directly after a landing on a foreign body
surface.25
For many experts, the new cardiovascular status reached
after equilibration does not correspond to a pathologic state, but
simply to a new physiologic equilibrium in weightlessness,
tailored to reduced loading conditions.25 This equilibrium
nevertheless is delicate and the tolerance to any additional
event (such as blood loss, anaphylaxis, or further reduction in
cardiac function) or interventional procedure (general anesthe-
sia, mechanical ventilation) may be compromised.26
A few precautions could reduce the risk of severe cardio-
vascular collapse in these situations. Vasopressors, in particular
alpha-agonists (phenylephrine, metaraminol, midodrine, nore-
pinephrine), should be readily available, including for contin-
uous infusion.36,64 Higher-than-usual doses could be
required.36 Beta-agonists and beta-antagonists should be used
with caution.36 Any clinically signiﬁcant relative or absolute
hypovolemia should be treated concomitantly with IV ﬂuids
and vasopressors. An IV ﬂuid loading procedure should be
carried out before the induction of general anesthesia.26 The
volemic status should be monitored during resuscitation using
objective parameters (eg, response to ﬂuid challenge on the
stroke volume or cardiac index).98 Electrolytes (potassium,magnesium) should be maintained within normal ranges to
limit the risk of arrhythmias.
Pharmacology in the Space Environment
Many factors may alter the pharmacokinetics and pharma-
codynamics of drugs in weightlessness; eg, weight changes,
redistribution of body ﬂuids, changes in renal perfusion, among
many others.99,100 Drugs may become ineffective or even toxic
after long-term storage.92 The clinical relevance of these
changes is unclear. Of interest for the anesthesiologist, the
use of depolarizing muscle blockers (succinylcholine) is contra-
indicated after prolonged exposure to microgravity due to
changes in the neuromuscular junction and risk of hyper-
kalemia.29,36 Rocuronium represents a valid alternative.101,102
Choice of Anesthetic Techniques
Given the speciﬁcities and challenges associated with
spaceﬂight, the choice of the most appropriate anesthetic
technique is not straightforward.
The experience of invasive medical procedures in
microgravity-exposed patients is very limited.3 To what extent
cardiovascular deconditioning will complicate the management
of a general anesthetic is unknown. Anesthesia has been induced
in animals in space and immediately after spaceﬂight.103 In
2002, a NASA working group concluded that the safe delivery
of anesthesia could be achievable with enough understanding of
the human physiology in space, as detailed by McSwain, MD, et
al in written communication. In the absence of strong evidence,
it appears sensible to formulate choices based on a worst-case
scenario approach and consider that astronauts in this setting will
be severely deconditioned, hypovolemic, at risk for arrhythmias,
difﬁcult to intubate, intolerant to succinylcholine, have a full
stomach, and be managed by nonmedical personnel with limited
training, if the crew medical doctor is incapacitated or dead.
Perhaps the most stringent limiting factor is that anesthesia
protocols should be achievable in a safe manner by a limited
crew of nonphysicians. In low-income countries, nonmedical
personnel regularly carry out anesthetic procedures with a
relatively low complication rate.104-106 Simpliﬁed protocols
could be carried out safely by nonphysicians.107 In addition to
physicians, astronauts, with their comprehensive skillset, are
ideal candidates to perform lifesaving medical procedures.
The extended discussion regarding regional anesthesia,
general anesthesia (GA), and conscious sedation has been laid
out previously.26,108,109 To summarize, the risks associated
with regional anesthesia are rather limited, but it requires
extensive training, whereas the situation is diametrically the
opposite for GA.26,109,110
The wide adoption of ultrasound techniques in anesthesia
has greatly simpliﬁed the execution of regional blocks and
increased their safety and success rate.111,112 With only 3
techniques (axillary brachial, femoral, and subgluteal sciatic
blocks), most surgeries of the upper and lower limbs are
possible. An axillary brachial block allows operating on the
arm below the shoulder level, and anesthesia of the entire leg
below mid-thigh can be achieved with a combined sciatic and
femoral nerve block.113 Using ultrasound-guided techniques, as
few as 10 procedures per block can be necessary to reach a
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IV sedation if necessary.
The relevance of including perimedullary techniques (spinal
and epidural) can be discussed. The effect and safety of spinal
anesthesia are most likely unpredictable in microgravity
because heavy local anesthetic solutions rely on gravity.108
Epidural techniques might be usable, but they require extensive
training and asepsis and carry signiﬁcant risks.108
GA would be suitable for any surgical condition.26 The
consequences of the ﬂuid shift and facial edema on the risk of
difﬁcult intubation are not documented, but could be of
concern. Intubation conditions in general are much more
favorable with muscle paralysis, which should therefore be
recommended.101,102 Astronauts should be tested for allergy
before ﬂight. The intubation success rate also is higher with
video laryngoscopes, especially for novice operators.115,116
Finally, gastric motility has been demonstrated to be slower
in space.32
Altogether, the safest procedure for GA appears to be a
rapid-sequence induction after IV ﬂuid loading, using drugs
that respect hemodynamic stability (most likely ketamine) and
orotracheal intubation with a video laryngoscope.26,107 For
limb or superﬁcial surgery, simple ultrasound-guided regionalblocks or local inﬁltration could be proposed, alone or in
combination with conscious sedation.3,109,110 Fracture blocks
are safe and efﬁcient for pain relief and mobilization.109 Minor
surgery can be performed after local inﬁltration.31CONCLUSION
Future space exploration missions will push beyond the
current limits of human experience in maintaining health and
performance of crew members in extreme settings. After
more than 5 decades of human presence in space, the
understanding of the space environment and human physiol-
ogy in weightlessness is advanced. Despite many challenges,
the safe delivery of an anesthetic procedure on previously
healthy individuals, given the current knowledge and tech-
nologies, could be possible, even by nonanesthesiologists.
There always will be risks in exploration, with deep space
being an extreme case of this, and these risks should not
constitute a block for future space exploration missions if the
crew are volunteers fully understanding and accepting of the
risks. Medical care for any individual with signiﬁcant
medical history (eg, “space tourist”) in the space environment
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